10x Genomics, Inc. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
10x Genomics, Inc. (TXG) reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $3.48 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2026-02-13
- 10x Genomics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2025 was $3.48M, a 39.35% decline from fiscal 2024.
- 10x Genomics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2024 was $5.74M, a 45.02% decline from fiscal 2023.
- 10x Genomics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $10.45M, a 77.01% increase from fiscal 2022.
- 10x Genomics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $5.90M, a 36.90% decline from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $3.48M 10-K · filed 2026-02-13 |
| 2024-12-31 | $5.74M 10-K · filed 2026-02-13 |
| 2023-12-31 | $10.45M 10-K · filed 2025-02-13 |
| 2022-12-31 | $5.90M 10-K · filed 2024-02-15 |
| 2021-12-31 | $9.35M 10-K · filed 2023-02-16 |
| 2020-12-31 | $8.56M 10-K · filed 2022-02-18 |
| 2019-12-31 | $2.24M 10-K · filed 2021-02-26 |
| 2018-12-31 | $1.36M 10-K · filed 2020-02-27 |